These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35129662)

  • 1. Promotion of cutaneous diabetic wound healing by subcutaneous administration of Wharton's jelly mesenchymal stem cells derived from umbilical cord.
    Nilforoushzadeh MA; Raoofi A; Afzali H; Gholami O; Zare S; Nasiry D; Khodaverdi Darian E; Rustamzadeh A; Alavi S; Ahmadi R; Alimohammadi A; Razzaghi Z; Safaie Naraghi Z; Mahmoudbeyk M; Amirkhani MA; Mousavi Khaneghah A
    Arch Dermatol Res; 2023 Mar; 315(2):147-159. PubMed ID: 35129662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical spray of Wharton's jelly mesenchymal stem cells derived from umbilical cord accelerates diabetic wound healing.
    Nilforoushzadeh MA; Afzali H; Raoofi A; Nouri M; Naser R; Gholami O; Nasiry D; Mohammadnia A; Razzaghi Z; Alimohammadi A; Naraghi ZS; Peyrovan A; Jahangiri F; Khodaverdi Darian E; Rustamzadeh A; Zare S
    J Cosmet Dermatol; 2022 Oct; 21(10):5156-5167. PubMed ID: 35478316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Fetal Bovine Acellular Dermal Matrix Seeded with Wharton's Jelly Mesenchymal Stem Cells for Healing Full-Thickness Skin Wounds.
    Mansour RN; Hasanzadeh E; Abasi M; Gholipourmalekabadi M; Mellati A; Enderami SE
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes from acellular Wharton's jelly of the human umbilical cord promotes skin wound healing.
    Bakhtyar N; Jeschke MG; Herer E; Sheikholeslam M; Amini-Nik S
    Stem Cell Res Ther; 2018 Jul; 9(1):193. PubMed ID: 30005703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silk fibroin scaffolds seeded with Wharton's jelly mesenchymal stem cells enhance re-epithelialization and reduce formation of scar tissue after cutaneous wound healing.
    Millán-Rivero JE; Martínez CM; Romecín PA; Aznar-Cervantes SD; Carpes-Ruiz M; Cenis JL; Moraleda JM; Atucha NM; García-Bernal D
    Stem Cell Res Ther; 2019 Apr; 10(1):126. PubMed ID: 31029166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wharton's jelly mesenchymal stem cells embedded in PF-127 hydrogel plus sodium ascorbyl phosphate combination promote diabetic wound healing in type 2 diabetic rat.
    Jiao Y; Chen X; Niu Y; Huang S; Wang J; Luo M; Shi G; Huang J
    Stem Cell Res Ther; 2021 Oct; 12(1):559. PubMed ID: 34717751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Fe
    Li X; Wei Z; Wu L; Lv H; Zhang Y; Li J; Yao H; Zhang H; Yang B; Xu X; Jiang J
    Biomater Sci; 2020 Oct; 8(19):5362-5375. PubMed ID: 32869785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transplanted mesenchymal stem cells isolated from Wharton's jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation.
    Azari O; Babaei H; Derakhshanfar A; Nematollahi-Mahani SN; Poursahebi R; Moshrefi M
    Vet Res Commun; 2011 Apr; 35(4):211-22. PubMed ID: 21340694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapy with human MSCs isolated from the umbilical cord Wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds.
    Ribeiro J; Pereira T; Amorim I; Caseiro AR; Lopes MA; Lima J; Gartner A; Santos JD; Bártolo PJ; Rodrigues JM; Mauricio AC; Luís AL
    Int J Med Sci; 2014; 11(10):979-87. PubMed ID: 25076843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Wharton's jelly-derived stem cells seeded/boron-loaded acellular scaffolds on the healing of full-thickness burn wounds in the rat model.
    Nikzad S; Same S; Safiri S; Dolati S; Roushangar Zineh B; Meshgi S; Roshangar L; Şahin F
    Biomed Mater; 2024 Feb; 19(2):. PubMed ID: 38364284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing.
    Doi H; Kitajima Y; Luo L; Yan C; Tateishi S; Ono Y; Urata Y; Goto S; Mori R; Masuzaki H; Shimokawa I; Hirano A; Li TS
    Sci Rep; 2016 Jan; 6():18844. PubMed ID: 26728342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.
    El-Demerdash RF; Hammad LN; Kamal MM; El Mesallamy HO
    Regen Med; 2015; 10(7):841-55. PubMed ID: 26541176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of Wharton's jelly mesenchymal stem cells encapsulated with Hydroactive® Gel promotes diabetic wound antifibrotic healing in type 2 diabetic rats.
    Jiao Y; Chen X; Nong B; Luo M; Niu Y; Huang S; Zhang J; Wei A; Huang J
    J Mater Chem B; 2022 Oct; 10(40):8330-8346. PubMed ID: 36168995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling.
    Arno AI; Amini-Nik S; Blit PH; Al-Shehab M; Belo C; Herer E; Tien CH; Jeschke MG
    Stem Cell Res Ther; 2014 Feb; 5(1):28. PubMed ID: 24564987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell and Spatial Transcriptomics Decodes Wharton's Jelly-Derived Mesenchymal Stem Cells Heterogeneity and a Subpopulation with Wound Repair Signatures.
    Chen P; Tang S; Li M; Wang D; Chen C; Qiu Y; Fang Z; Zhang H; Gao H; Weng H; Hu K; Lin J; Lin Q; Tan Y; Li S; Chen J; Chen L; Chen X
    Adv Sci (Weinh); 2023 Feb; 10(4):e2204786. PubMed ID: 36504438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of umbilical cord-derived stem cells for diabetes mellitus: a meta-analysis study.
    Kassem DH; Kamal MM
    Stem Cell Res Ther; 2020 Nov; 11(1):484. PubMed ID: 33198815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
    Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
    Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats.
    Hu J; Wang F; Sun R; Wang Z; Yu X; Wang L; Gao H; Zhao W; Yan S; Wang Y
    Endocrine; 2014 Mar; 45(2):279-87. PubMed ID: 23686639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.